Daniel Donovan
Director at Intensity Therapeutics, Inc. (INTS)
Daniel Donovan has filed 5 insider reports with the SEC since June 2022, as director at Intensity Therapeutics, Inc. (INTS) and director at Panbela Therapeutics, Inc. (PBLA). The latest filing, on July 20, 2026, reports grant or award at Intensity Therapeutics, Inc. (INTS).
- Filings
- 5
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Daniel Donovan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $2.64 | Jul 20, 2026 | |||||
| Directorsince June 2022 | 71,535 | Mar 29, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 16, 2026INTSSEC Form 4 filed by Director Donovan DanielForm 4Grant or award
- May 2, 2025INTSSEC Form 4 filed by Director Donovan DanielForm 4Grant or award
- Mar 6, 2024INTSSEC Form 4 filed by Donovan DanielForm 4Grant or award
- Mar 27, 2023PBLASEC Form 4 filed by Donovan DanielForm 4Grant or award
- Jun 15, 2022PBLASEC Form 3: New insider Donovan Daniel claimed ownership of 310,319 sharesForm 3New insider
Compare Daniel Donovan with
- Daniel Donovan vs Dubin Thomas I H1 shared
- Daniel Donovan vs Mark A Goldberg1 shared
- Daniel Donovan vs Emer Leahy1 shared
- Daniel Donovan vs John M Wesolowski1 shared
- Daniel Donovan vs Joseph Talamo1 shared
- Daniel Donovan vs Lewis H Bender1 shared
Other insiders at the same companies
- Dubin Thomas I HINTS
- Mark A GoldbergINTS
- Emer LeahyINTS
- John M WesolowskiINTS
- Joseph TalamoINTS
- Lewis H BenderINTS
- Nant Capital, LLCPBLA
Questions about Daniel Donovan
- What is Daniel Donovan's role at Intensity Therapeutics, Inc.?
- Daniel Donovan reports to the SEC as director at Intensity Therapeutics, Inc. (INTS), according to the latest filing on July 20, 2026. Daniel Donovan has also filed as director at Panbela Therapeutics, Inc. (PBLA).
- How many shares does Daniel Donovan own?
- After the latest filing that states it, Daniel Donovan directly owned 71,535 shares of Panbela Therapeutics, Inc. (PBLA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Daniel Donovan bought or sold stock recently?
- No open-market purchases or sales by Daniel Donovan are on file. The filings report grant or award.
- How do I get alerts when Daniel Donovan files?
- Follow Daniel Donovan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Donovan (SEC CIK 0001934188). Totals count each trade once, skipping amendments whose original is on file, from Jun 24, 2022 on. View on SEC EDGAR